Click for best price
RNA Drugs Market Size, Share 2022
Market Analysis and Insights: Global RNA Drugs Market
The global RNA Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global RNA Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global RNA Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global RNA Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global RNA Drugs market.
Global RNA Drugs Scope and Market Size
RNA Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global RNA Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
siRNA
ASO
miRNA
Nucleic Acid Aptamers
Segment by Application
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
By Company
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes RNA Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of RNA Drugs, with price, sales, revenue, and global market share of RNA Drugs from 2019 to 2022.
Chapter 3, the RNA Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RNA Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the RNA Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of RNA Drugs.
Chapter 13, 14, and 15, to describe RNA Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 RNA Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global RNA Drugs Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
117 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 RNA Drugs Product Introduction
1.2 Market by Type
1.2.1 Global RNA Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 siRNA
1.2.3 ASO
1.2.4 miRNA
1.2.5 Nucleic Acid Aptamers
1.3 Market by Application
1.3.1 Global RNA Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global RNA Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global RNA Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global RNA Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global RNA Drugs Sales by Region
2.4.1 Global RNA Drugs Sales by Region (2017-2022)
2.4.2 Global Sales RNA Drugs by Region (2023-2028)
2.5 Global RNA Drugs Revenue by Region
2.5.1 Global RNA Drugs Revenue by Region (2017-2022)
2.5.2 Global RNA Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global RNA Drugs Sales by Manufacturers
3.1.1 Global Top RNA Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global RNA Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of RNA Drugs in 2021
3.2 Global RNA Drugs Revenue by Manufacturers
3.2.1 Global RNA Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global RNA Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by RNA Drugs Revenue in 2021
3.3 Global RNA Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global RNA Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global RNA Drugs Sales by Type
4.1.1 Global RNA Drugs Historical Sales by Type (2017-2022)
4.1.2 Global RNA Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global RNA Drugs Sales Market Share by Type (2017-2028)
4.2 Global RNA Drugs Revenue by Type
4.2.1 Global RNA Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global RNA Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global RNA Drugs Revenue Market Share by Type (2017-2028)
4.3 Global RNA Drugs Price by Type
4.3.1 Global RNA Drugs Price by Type (2017-2022)
4.3.2 Global RNA Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global RNA Drugs Sales by Application
5.1.1 Global RNA Drugs Historical Sales by Application (2017-2022)
5.1.2 Global RNA Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global RNA Drugs Sales Market Share by Application (2017-2028)
5.2 Global RNA Drugs Revenue by Application
5.2.1 Global RNA Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global RNA Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global RNA Drugs Revenue Market Share by Application (2017-2028)
5.3 Global RNA Drugs Price by Application
5.3.1 Global RNA Drugs Price by Application (2017-2022)
5.3.2 Global RNA Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America RNA Drugs Market Size by Type
6.1.1 North America RNA Drugs Sales by Type (2017-2028)
6.1.2 North America RNA Drugs Revenue by Type (2017-2028)
6.2 North America RNA Drugs Market Size by Application
6.2.1 North America RNA Drugs Sales by Application (2017-2028)
6.2.2 North America RNA Drugs Revenue by Application (2017-2028)
6.3 North America RNA Drugs Market Size by Country
6.3.1 North America RNA Drugs Sales by Country (2017-2028)
6.3.2 North America RNA Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe RNA Drugs Market Size by Type
7.1.1 Europe RNA Drugs Sales by Type (2017-2028)
7.1.2 Europe RNA Drugs Revenue by Type (2017-2028)
7.2 Europe RNA Drugs Market Size by Application
7.2.1 Europe RNA Drugs Sales by Application (2017-2028)
7.2.2 Europe RNA Drugs Revenue by Application (2017-2028)
7.3 Europe RNA Drugs Market Size by Country
7.3.1 Europe RNA Drugs Sales by Country (2017-2028)
7.3.2 Europe RNA Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific RNA Drugs Market Size by Type
8.1.1 Asia Pacific RNA Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific RNA Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific RNA Drugs Market Size by Application
8.2.1 Asia Pacific RNA Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific RNA Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific RNA Drugs Market Size by Region
8.3.1 Asia Pacific RNA Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific RNA Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America RNA Drugs Market Size by Type
9.1.1 Latin America RNA Drugs Sales by Type (2017-2028)
9.1.2 Latin America RNA Drugs Revenue by Type (2017-2028)
9.2 Latin America RNA Drugs Market Size by Application
9.2.1 Latin America RNA Drugs Sales by Application (2017-2028)
9.2.2 Latin America RNA Drugs Revenue by Application (2017-2028)
9.3 Latin America RNA Drugs Market Size by Country
9.3.1 Latin America RNA Drugs Sales by Country (2017-2028)
9.3.2 Latin America RNA Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa RNA Drugs Market Size by Type
10.1.1 Middle East and Africa RNA Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa RNA Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa RNA Drugs Market Size by Application
10.2.1 Middle East and Africa RNA Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa RNA Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa RNA Drugs Market Size by Country
10.3.1 Middle East and Africa RNA Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa RNA Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Overview
11.2.3 Roche RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Roche RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 Sanofi-Aventis
11.3.1 Sanofi-Aventis Corporation Information
11.3.2 Sanofi-Aventis Overview
11.3.3 Sanofi-Aventis RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi-Aventis RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi-Aventis Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Corporation Information
11.4.2 Abbott Laboratories Overview
11.4.3 Abbott Laboratories RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Abbott Laboratories RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Abbott Laboratories Recent Developments
11.5 Arrowhead Pharmaceuticals
11.5.1 Arrowhead Pharmaceuticals Corporation Information
11.5.2 Arrowhead Pharmaceuticals Overview
11.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Arrowhead Pharmaceuticals RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Arrowhead Pharmaceuticals Recent Developments
11.6 Benitec Biopharma
11.6.1 Benitec Biopharma Corporation Information
11.6.2 Benitec Biopharma Overview
11.6.3 Benitec Biopharma RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Benitec Biopharma RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Benitec Biopharma Recent Developments
11.7 Calimmune Inc
11.7.1 Calimmune Inc Corporation Information
11.7.2 Calimmune Inc Overview
11.7.3 Calimmune Inc RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Calimmune Inc RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Calimmune Inc Recent Developments
11.8 Dicerna
11.8.1 Dicerna Corporation Information
11.8.2 Dicerna Overview
11.8.3 Dicerna RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Dicerna RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dicerna Recent Developments
11.9 Gradalis
11.9.1 Gradalis Corporation Information
11.9.2 Gradalis Overview
11.9.3 Gradalis RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Gradalis RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Gradalis Recent Developments
11.10 Quark
11.10.1 Quark Corporation Information
11.10.2 Quark Overview
11.10.3 Quark RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Quark RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Quark Recent Developments
11.11 RXi
11.11.1 RXi Corporation Information
11.11.2 RXi Overview
11.11.3 RXi RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 RXi RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 RXi Recent Developments
11.12 Senesco
11.12.1 Senesco Corporation Information
11.12.2 Senesco Overview
11.12.3 Senesco RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Senesco RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Senesco Recent Developments
11.13 Silence Therapeutics
11.13.1 Silence Therapeutics Corporation Information
11.13.2 Silence Therapeutics Overview
11.13.3 Silence Therapeutics RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Silence Therapeutics RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Silence Therapeutics Recent Developments
11.14 Silenseed
11.14.1 Silenseed Corporation Information
11.14.2 Silenseed Overview
11.14.3 Silenseed RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Silenseed RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Silenseed Recent Developments
11.15 Tekmira
11.15.1 Tekmira Corporation Information
11.15.2 Tekmira Overview
11.15.3 Tekmira RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Tekmira RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Tekmira Recent Developments
11.16 Alnylam Pharmaceuticals
11.16.1 Alnylam Pharmaceuticals Corporation Information
11.16.2 Alnylam Pharmaceuticals Overview
11.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Alnylam Pharmaceuticals RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Alnylam Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 RNA Drugs Industry Chain Analysis
12.2 RNA Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 RNA Drugs Production Mode & Process
12.4 RNA Drugs Sales and Marketing
12.4.1 RNA Drugs Sales Channels
12.4.2 RNA Drugs Distributors
12.5 RNA Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 RNA Drugs Industry Trends
13.2 RNA Drugs Market Drivers
13.3 RNA Drugs Market Challenges
13.4 RNA Drugs Market Restraints
14 Key Findings in The Global RNA Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global RNA Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of siRNA
Table 3. Major Manufacturers of ASO
Table 4. Major Manufacturers of miRNA
Table 5. Major Manufacturers of Nucleic Acid Aptamers
Table 6. Global RNA Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global RNA Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global RNA Drugs Sales by Region (2017-2022) & (K Units)
Table 9. Global RNA Drugs Sales Market Share by Region (2017-2022)
Table 10. Global RNA Drugs Sales by Region (2023-2028) & (K Units)
Table 11. Global RNA Drugs Sales Market Share by Region (2023-2028)
Table 12. Global RNA Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global RNA Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global RNA Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global RNA Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global RNA Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global RNA Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global RNA Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global RNA Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. RNA Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global RNA Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global RNA Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Drugs as of 2021)
Table 23. RNA Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers RNA Drugs Product Offered
Table 25. Date of Manufacturers Enter into RNA Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 28. Global RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 29. Global RNA Drugs Sales Share by Type (2017-2022)
Table 30. Global RNA Drugs Sales Share by Type (2023-2028)
Table 31. Global RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global RNA Drugs Revenue Share by Type (2017-2022)
Table 34. Global RNA Drugs Revenue Share by Type (2023-2028)
Table 35. RNA Drugs Price by Type (2017-2022) & (USD/Unit)
Table 36. Global RNA Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 38. Global RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 39. Global RNA Drugs Sales Share by Application (2017-2022)
Table 40. Global RNA Drugs Sales Share by Application (2023-2028)
Table 41. Global RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global RNA Drugs Revenue Share by Application (2017-2022)
Table 44. Global RNA Drugs Revenue Share by Application (2023-2028)
Table 45. RNA Drugs Price by Application (2017-2022) & (USD/Unit)
Table 46. Global RNA Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 48. North America RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 49. North America RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 52. North America RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 53. North America RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 56. North America RNA Drugs Sales by Country (2023-2028) & (K Units)
Table 57. North America RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America RNA Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 60. Europe RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 61. Europe RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Europe RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 65. Europe RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 68. Europe RNA Drugs Sales by Country (2023-2028) & (K Units)
Table 69. Europe RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe RNA Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific RNA Drugs Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific RNA Drugs Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific RNA Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific RNA Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 84. Latin America RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 85. Latin America RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 88. Latin America RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 89. Latin America RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 92. Latin America RNA Drugs Sales by Country (2023-2028) & (K Units)
Table 93. Latin America RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America RNA Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa RNA Drugs Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa RNA Drugs Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa RNA Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa RNA Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa RNA Drugs Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa RNA Drugs Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa RNA Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa RNA Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa RNA Drugs Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa RNA Drugs Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa RNA Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa RNA Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Pfizer RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Roche Corporation Information
Table 113. Roche Description and Major Businesses
Table 114. Roche RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Roche RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Roche Recent Developments
Table 117. Sanofi-Aventis Corporation Information
Table 118. Sanofi-Aventis Description and Major Businesses
Table 119. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Sanofi-Aventis RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi-Aventis Recent Developments
Table 122. Abbott Laboratories Corporation Information
Table 123. Abbott Laboratories Description and Major Businesses
Table 124. Abbott Laboratories RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Abbott Laboratories RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Abbott Laboratories Recent Developments
Table 127. Arrowhead Pharmaceuticals Corporation Information
Table 128. Arrowhead Pharmaceuticals Description and Major Businesses
Table 129. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Arrowhead Pharmaceuticals RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Arrowhead Pharmaceuticals Recent Developments
Table 132. Benitec Biopharma Corporation Information
Table 133. Benitec Biopharma Description and Major Businesses
Table 134. Benitec Biopharma RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Benitec Biopharma RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Benitec Biopharma Recent Developments
Table 137. Calimmune Inc Corporation Information
Table 138. Calimmune Inc Description and Major Businesses
Table 139. Calimmune Inc RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Calimmune Inc RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Calimmune Inc Recent Developments
Table 142. Dicerna Corporation Information
Table 143. Dicerna Description and Major Businesses
Table 144. Dicerna RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Dicerna RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Dicerna Recent Developments
Table 147. Gradalis Corporation Information
Table 148. Gradalis Description and Major Businesses
Table 149. Gradalis RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Gradalis RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Gradalis Recent Developments
Table 152. Quark Corporation Information
Table 153. Quark Description and Major Businesses
Table 154. Quark RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Quark RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Quark Recent Developments
Table 157. RXi Corporation Information
Table 158. RXi Description and Major Businesses
Table 159. RXi RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. RXi RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. RXi Recent Developments
Table 162. Senesco Corporation Information
Table 163. Senesco Description and Major Businesses
Table 164. Senesco RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 165. Senesco RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Senesco Recent Developments
Table 167. Silence Therapeutics Corporation Information
Table 168. Silence Therapeutics Description and Major Businesses
Table 169. Silence Therapeutics RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 170. Silence Therapeutics RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Silence Therapeutics Recent Developments
Table 172. Silenseed Corporation Information
Table 173. Silenseed Description and Major Businesses
Table 174. Silenseed RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 175. Silenseed RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Silenseed Recent Developments
Table 177. Tekmira Corporation Information
Table 178. Tekmira Description and Major Businesses
Table 179. Tekmira RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 180. Tekmira RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Tekmira Recent Developments
Table 182. Alnylam Pharmaceuticals Corporation Information
Table 183. Alnylam Pharmaceuticals Description and Major Businesses
Table 184. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 185. Alnylam Pharmaceuticals RNA Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Alnylam Pharmaceuticals Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. RNA Drugs Distributors List
Table 190. RNA Drugs Customers List
Table 191. RNA Drugs Market Trends
Table 192. RNA Drugs Market Drivers
Table 193. RNA Drugs Market Challenges
Table 194. RNA Drugs Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA Drugs Product Picture
Figure 3. Global RNA Drugs Market Share by Type in 2021 & 2028
Figure 3. siRNA Product Picture
Figure 4. ASO Product Picture
Figure 5. miRNA Product Picture
Figure 6. Nucleic Acid Aptamers Product Picture
Figure 7. Global RNA Drugs Market Share by Application in 2021 & 2028
Figure 8. Cancer
Figure 9. Diabetes
Figure 10. Tuberculosis
Figure 11. Cardiovascular Diseases
Figure 12. Others
Figure 13. RNA Drugs Report Years Considered
Figure 14. Global RNA Drugs Sales 2017-2028 (K Units)
Figure 15. Global RNA Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global RNA Drugs Revenue 2017-2028 (US$ Million)
Figure 17. Global RNA Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global RNA Drugs Sales Market Share by Region (2017-2022)
Figure 19. Global RNA Drugs Sales Market Share by Region (2023-2028)
Figure 20. North America RNA Drugs Sales YoY (2017-2028) & (K Units)
Figure 21. North America RNA Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe RNA Drugs Sales YoY (2017-2028) & (K Units)
Figure 23. Europe RNA Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific RNA Drugs Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific RNA Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America RNA Drugs Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America RNA Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa RNA Drugs Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa RNA Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The RNA Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of RNA Drugs in the World: Market Share by RNA Drugs Revenue in 2021
Figure 32. Global RNA Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global RNA Drugs Sales Market Share by Type (2017-2028)
Figure 34. Global RNA Drugs Revenue Market Share by Type (2017-2028)
Figure 35. Global RNA Drugs Sales Market Share by Application (2017-2028)
Figure 36. Global RNA Drugs Revenue Market Share by Application (2017-2028)
Figure 37. North America RNA Drugs Sales Market Share by Type (2017-2028)
Figure 38. North America RNA Drugs Revenue Market Share by Type (2017-2028)
Figure 39. North America RNA Drugs Sales Market Share by Application (2017-2028)
Figure 40. North America RNA Drugs Revenue Market Share by Application (2017-2028)
Figure 41. North America RNA Drugs Sales Share by Country (2017-2028)
Figure 42. North America RNA Drugs Revenue Share by Country (2017-2028)
Figure 43. U.S. RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Canada RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Europe RNA Drugs Sales Market Share by Type (2017-2028)
Figure 46. Europe RNA Drugs Revenue Market Share by Type (2017-2028)
Figure 47. Europe RNA Drugs Sales Market Share by Application (2017-2028)
Figure 48. Europe RNA Drugs Revenue Market Share by Application (2017-2028)
Figure 49. Europe RNA Drugs Sales Share by Country (2017-2028)
Figure 50. Europe RNA Drugs Revenue Share by Country (2017-2028)
Figure 51. Germany RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. France RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Italy RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Russia RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific RNA Drugs Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific RNA Drugs Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific RNA Drugs Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific RNA Drugs Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific RNA Drugs Sales Share by Region (2017-2028)
Figure 61. Asia Pacific RNA Drugs Revenue Share by Region (2017-2028)
Figure 62. China RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Japan RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. India RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Australia RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America RNA Drugs Sales Market Share by Type (2017-2028)
Figure 73. Latin America RNA Drugs Revenue Market Share by Type (2017-2028)
Figure 74. Latin America RNA Drugs Sales Market Share by Application (2017-2028)
Figure 75. Latin America RNA Drugs Revenue Market Share by Application (2017-2028)
Figure 76. Latin America RNA Drugs Sales Share by Country (2017-2028)
Figure 77. Latin America RNA Drugs Revenue Share by Country (2017-2028)
Figure 78. Mexico RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa RNA Drugs Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa RNA Drugs Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa RNA Drugs Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa RNA Drugs Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa RNA Drugs Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa RNA Drugs Revenue Share by Country (2017-2028)
Figure 87. Turkey RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 89. U.A.E RNA Drugs Revenue (2017-2028) & (US$ Million)
Figure 90. RNA Drugs Value Chain
Figure 91. RNA Drugs Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
